These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Increased recognition of non-O157 Shiga toxin-producing Escherichia coli infections in the United States during 2000-2010: epidemiologic features and comparison with E. coli O157 infections. Gould LH; Mody RK; Ong KL; Clogher P; Cronquist AB; Garman KN; Lathrop S; Medus C; Spina NL; Webb TH; White PL; Wymore K; Gierke RE; Mahon BE; Griffin PM; Foodborne Pathog Dis; 2013 May; 10(5):453-60. PubMed ID: 23560425 [TBL] [Abstract][Full Text] [Related]
3. Petting zoos as sources of Shiga toxin-producing Escherichia coli (STEC) infections. Schlager S; Lepuschitz S; Ruppitsch W; Ableitner O; Pietzka A; Neubauer S; Stöger A; Lassnig H; Mikula C; Springer B; Allerberger F Int J Med Microbiol; 2018 Oct; 308(7):927-932. PubMed ID: 30257809 [TBL] [Abstract][Full Text] [Related]
4. Characteristics of O157 versus non-O157 Shiga toxin-producing Escherichia coli infections in Minnesota, 2000-2006. Hedican EB; Medus C; Besser JM; Juni BA; Koziol B; Taylor C; Smith KE Clin Infect Dis; 2009 Aug; 49(3):358-64. PubMed ID: 19548834 [TBL] [Abstract][Full Text] [Related]
5. Surveillance of hemolytic uremic syndrome in children less than 15 years of age, a system to monitor O157 and non-O157 Shiga toxin-producing Escherichia coli infections in France, 1996-2006. Espié E; Grimont F; Mariani-Kurkdjian P; Bouvet P; Haeghebaert S; Filliol I; Loirat C; Decludt B; Minh NN; Vaillant V; de Valk H Pediatr Infect Dis J; 2008 Jul; 27(7):595-601. PubMed ID: 18520972 [TBL] [Abstract][Full Text] [Related]
15. Increasing incidence of non-O157 Shiga toxin-producing Escherichia coli (STEC) in Michigan and association with clinical illness. Tseng M; Sha Q; Rudrik JT; Collins J; Henderson T; Funk JA; Manning SD Epidemiol Infect; 2016 May; 144(7):1394-405. PubMed ID: 26584572 [TBL] [Abstract][Full Text] [Related]
16. Update on the ongoing outbreak of haemolytic uraemic syndrome due to Shiga toxin-producing Escherichia coli (STEC) serotype O104, Germany, May 2011. Askar M; Faber MS; Frank C; Bernard H; Gilsdorf A; Fruth A; Prager R; Hohle M; Suess T; Wadl M; Krause G; Stark K; Werber D Euro Surveill; 2011 Jun; 16(22):. PubMed ID: 21663710 [No Abstract] [Full Text] [Related]
17. Sorbitol-fermenting Shiga toxin-producing Escherichia coli O157 in Austria. Orth D; Grif K; Zimmerhackl LB; Würzner R Wien Klin Wochenschr; 2009; 121(3-4):108-12. PubMed ID: 19280135 [TBL] [Abstract][Full Text] [Related]
18. Community-wide outbreaks of haemolytic uraemic syndrome associated with Shiga toxin-producing Escherichia coli O26 in Italy and Romania: a new challenge for the European Union. Severi E; Vial F; Peron E; Mardh O; Niskanen T; Takkinen J Euro Surveill; 2016 Dec; 21(49):. PubMed ID: 27983509 [No Abstract] [Full Text] [Related]
19. Relationship between pathogenicity for humans and stx genotype in Shiga toxin-producing Escherichia coli serotype O157. Kawano K; Okada M; Haga T; Maeda K; Goto Y Eur J Clin Microbiol Infect Dis; 2008 Mar; 27(3):227-32. PubMed ID: 18071766 [TBL] [Abstract][Full Text] [Related]
20. Shiga Toxin-Producing Escherichia coli O157, England and Wales, 1983-2012. Adams NL; Byrne L; Smith GA; Elson R; Harris JP; Salmon R; Smith R; O'Brien SJ; Adak GK; Jenkins C Emerg Infect Dis; 2016 Apr; 22(4):590-7. PubMed ID: 26982243 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]